Healthcare -
Biotechnology - NASDAQ - US
$ 3.97
-2.7 %
$ 38.7 M
Market Cap
-0.11
P/E
BLUE - SHORT-TERM DEBT
Short-term Debt BLUE - bluebird bio, Inc.
106 M
LAST VALUE
51.24%
2 YEAR CAGR
136.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR